G
Garrett E. Foulke
Researcher at University of California, Davis
Publications - 31
Citations - 2179
Garrett E. Foulke is an academic researcher from University of California, Davis. The author has contributed to research in topics: Pulmonary edema & Managed care. The author has an hindex of 13, co-authored 31 publications receiving 2154 citations. Previous affiliations of Garrett E. Foulke include Stanford University & University Hospitals of Cleveland.
Papers
More filters
Journal ArticleDOI
Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. A randomized, double-blind, placebo-controlled trial. The HA-1A Sepsis Study Group.
Elizabeth J. Ziegler,Charles J. Fisher,Charles L. Sprung,Richard C. Straube,Jerald C. Sadoff,Garrett E. Foulke,CH Wortel,Fink Mp,Dellinger Rp,Nelson N.H. Teng +9 more
TL;DR: A randomized, double-blind trial in patients with sepsis and a presumed diagnosis of gram-negative infection was conducted in this article, where the patients received either a single 100mg intravenous dose of HA-1A or placebo.
Journal ArticleDOI
Superiority of activated charcoal alone compared with ipecac and activated charcoal in the treatment of acute toxic ingestions.
TL;DR: Together, these data are consistent with the recommendation that ED treatment with activated charcoal alone be the gastrointestinal decontamination procedure of choice for the routine mildly-to-moderately orally poisoned adult patient.
Journal ArticleDOI
Effective measures for reducing blood loss from diagnostic laboratory tests in intensive care unit patients
TL;DR: DBL is a major health problem for the ICU patient and routine use of small specimen volumes in this setting is warranted, and recording DBL for use in physician decision-making also significantly impacts this problem.
Journal ArticleDOI
Randomized, prospective trial of fenoldopam vs sodium nitroprusside in the treatment of acute severe hypertension. Fenoldopam Study Group.
TL;DR: For patients who had acute severe hypertension, FNP and NTP were equivalent in terms of efficacy and acute adverse events, and FNP may have advantages in selected subsets of patients.
Journal ArticleDOI
High-dose versus standard-dose epinephrine treatment of cardiac arrest after failure of standard therapy.
TL;DR: High‐dose epinephrine is used in emergency department patients in cardiac arrest after SDE failed to improve asystole or ventricular fibrillation to assess the efficacy of HDE compared with standard‐dose SDE.